| Name | Title | Contact Details |
|---|
BeWellNM has established its online communities to serve as informative and engaging resources for the public. Our goal is to facilitate a constructive, open dialogue around the Patient Protection and Affordable Care Act, and to answer questions relate...
As a major provider of advanced health and medical services for more than 100 years, Sharon Regional is a major resource for the northwest Pennsylvania-northeast Ohio region.
Research Diets is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Valencell develops performance biometric sensor technology and provides this patent-protected technology to consumer electronics manufacturers, wearable and hearable device makers, sports and fitness brands, medical device makers, and gaming companies for integration into their products.